| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 03/01/2006 | EP1196143B1 Use of an electric field for sensitising red blood cells to ultrasound |
| 03/01/2006 | CN1741822A Device and process for treating a liquid medium using ultrasound in preventing the growth of hyperproliferative or infected cells |
| 03/01/2006 | CN1741788A Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same |
| 02/28/2006 | USRE38994 Pyropheophorbides conjugates and their use in photodynamic therapy |
| 02/23/2006 | WO2006020979A2 Factor vii conjugates for selectively treating neovascularization disorders |
| 02/23/2006 | US20060041219 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 02/23/2006 | US20060040914 Meso-substituted porphyrins |
| 02/23/2006 | US20060040913 2-Aza-21-carba-5,10,15,20-tetra(3-methoxyphenyl)prophyrin (NC-m-TMPP; for photodynamic therapy, of cancerous and other diseased tissues, Barrett's Oesophagus, ARMD, keratinosis, diabetic neuropathy, peripheral vascular disease, coronary artery disease, disorders arising from bacterial or viral infection |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/23/2006 | US20060039965 Drug delivery system for hydrophobic drugs |
| 02/23/2006 | US20060039856 Magnetic resonance with stimulation |
| 02/21/2006 | US7001991 transferrin-doxorubicin linked with glutaraldehyde; low-toxicity, side-effect reduction |
| 02/16/2006 | CA2584970A1 Method for the treatment of mammalian skin tissues via pulse irradiation in the presence of a photoactive compound |
| 02/15/2006 | EP1456359B1 Preparation of vaccines using photosensitizer and light |
| 02/15/2006 | EP1087793B1 Material for differently modifying the optical properties of different cells and device for applying this material |
| 02/15/2006 | EP1041985B1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 02/14/2006 | US6997863 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 02/14/2006 | CA2199400C Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 02/09/2006 | WO2006015016A2 Photodynamic therapy and compositions for treating ocular glaucoma |
| 02/09/2006 | WO2006013227A2 METHYLAMINE RISKS and TREATMENT WITH N-DERIVATIVES OF HYPERACTIVITY, DEPRESSION AND ALCOHOLISM |
| 02/09/2006 | WO2002089750A3 Apparatus and method of photodynamic eradication of organisms utilizing pyrrolnitrin |
| 02/09/2006 | US20060029614 Methods and compositions for treating gastroparesis |
| 02/09/2006 | US20060029613 Orally administered; activated and conditioned yeast cells cultured in electromagnetic fields |
| 02/09/2006 | CA2576102A1 Therapy device and related accessories, compositions, and treatment methods |
| 02/08/2006 | EP1309328A4 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 02/07/2006 | US6995260 Carboranylporphyrins and uses thereof |
| 02/02/2006 | WO2006012359A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 02/02/2006 | WO2006012264A1 Compounds of the inventions of guanylyl cyclase c |
| 02/02/2006 | WO2006012140A1 Carboranylporphyrins and uses thereof |
| 02/02/2006 | US20060024704 Detection of markers in nascent proteins |
| 02/02/2006 | US20060024326 Biological compositions and methods for treatment of colorectal cancer |
| 02/02/2006 | US20060024325 Orally administered; activated and conditioned yeast cells; culturing yeast cells of Saccharomyces cerevisiae Hansen strain electromagnetic fields |
| 02/02/2006 | CA2573018A1 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 02/02/2006 | CA2572287A1 Carboranylporphyrins and uses thereof |
| 01/31/2006 | US6992107 (photodynamic therapy); branched alkyl and substituted benzyl ALA esters are precursors to in vitro porphyrin formation upon illumination; enhanced tumor selectivity, improved uptake, reduced pain sensation when administered; in vitro diagnosis kit |
| 01/31/2006 | US6991776 Halogenated xanthene or halogenated xanthene derivative; cancer treatment |
| 01/26/2006 | WO2005120573A3 Cationic bacteriochlorophyll derivatives and uses thereof |
| 01/26/2006 | US20060019876 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 01/26/2006 | US20060018956 Dermal application system for aminolevulinic acid-derivatives |
| 01/25/2006 | EP1127265A4 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor |
| 01/24/2006 | US6989443 Carboranylporphyrins and uses thereof |
| 01/24/2006 | US6989383 Method of treating cancer |
| 01/24/2006 | US6989253 Biological compositions and methods for treatment of testicular cancer |
| 01/19/2006 | WO2006007261A1 Photo-triggered release of active substances from dendrimer-photosensitizer complexes |
| 01/19/2006 | WO2005107701A8 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules |
| 01/18/2006 | EP1615639A2 Targeted bone marrow protection agents |
| 01/18/2006 | EP1615552A2 Sapphyrins and uses thereof |
| 01/18/2006 | EP1100385B1 Ultrasound assembly for use with a catheter |
| 01/17/2006 | US6987012 Biological compositions and methods for treatment of colorectal cancer |
| 01/17/2006 | US6986888 Method for treating mammals with modified mammalian blood |
| 01/17/2006 | US6986740 administering an ultrasound contrast agent such as Rose Bengal; a portion of the contrast agent being retained in tissue of interest; and imaging the tissue with ultrasound to identify the tissue |
| 01/12/2006 | WO2006003463A1 Method for introducing a pna molecule conjugated to a positively charged peptide into the cytosol and/or the nucleus by photochemical internalisation (pci) |
| 01/12/2006 | WO2006003305A1 Ultrasonic wave transducer for making surface layers of the epidermis permeable |
| 01/12/2006 | US20060008475 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors |
| 01/12/2006 | CA2571696A1 Method for introducing a pna molecule conjugated to a positively charged peptide into the cytosol and/or the nucleus by photochemical internalisation (pci) |
| 01/11/2006 | EP1614694A1 Titanium dioxide complex having molecule distinguishability |
| 01/11/2006 | EP1613351A1 Targeted agents for both photodiagnosis and photodynamic therapy |
| 01/11/2006 | EP1613278A1 A topical agent containing niacin for application to the skin prior to luminous treatment |
| 01/10/2006 | US6984656 Core modified porphyrins |
| 01/10/2006 | US6984655 Photodynamic therapy for selectively closing neovasa in eyeground tissue |
| 01/10/2006 | US6984619 Method for protection against tumor metastasis formation |
| 01/10/2006 | US6984508 Biological compositions and methods for treatment of cervical cancer |
| 01/10/2006 | US6984507 Biological compositions and methods for treatment of lung cancer |
| 01/10/2006 | US6984395 Drug delivery system for hydrophobic drugs |
| 01/10/2006 | CA2351620C Nano-emulsion of 5-aminolevulinic acid |
| 01/05/2006 | WO2005065282A3 Remote magnetically induced treatment of cancer |
| 01/05/2006 | US20060003983 Photosensitizer and method for production thereof |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610821A2 Agent for the photodynamic diagnosis and therapy of malignant tumors |
| 01/04/2006 | EP0884042A4 Medicament and method of treating an organism with medicaments |
| 01/04/2006 | CN1234415C Medical powder |
| 12/29/2005 | WO2005123105A1 Phototoxic compounds |
| 12/29/2005 | WO2005091704A3 Magnetic nanoparticles of noble metals |
| 12/29/2005 | WO2003068155A3 Inhibition of vegf receptor signaling reverses tumor resistance to radiotherapy |
| 12/29/2005 | US20050287158 The p65 subunit of nf-kb for the radiosensitization of cells |
| 12/29/2005 | US20050287073 Carboranylporphyrins and uses thereof |
| 12/29/2005 | US20050287067 Compounds of the inventions of guanylyl cyclase C |
| 12/29/2005 | DE102005022817A1 Kontrastmittel für ein kombinierte Betriebsarten verwendendes Bildgebungssystem und zugehörige Verfahren und Systeme Contrast agents for a combined modes-use imaging system and associated methods and systems |
| 12/28/2005 | EP1609465A1 Ophthalmic drug delivery system using polymer micell |
| 12/28/2005 | EP1608384A2 Therapy for primary and metastatic cancers |
| 12/28/2005 | EP1161418B1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 12/28/2005 | EP1094838B1 Retarding tumor angiogenesis related growth |
| 12/28/2005 | CN1714091A Meso-substituted porphyrins |
| 12/27/2005 | US6979562 orally administering yeast cells cultured in presence of alternating electric field having a frequency in the range of 9500-13500 MHz and a field strength in the range of 200-450 mV/cm |
| 12/27/2005 | US6979466 Iron oxide core with overcoating shell; antitumor agents |
| 12/22/2005 | WO2005120590A1 Activatable particles, preparations and uses. |
| 12/22/2005 | WO2005120573A2 Cationic bacteriochlorophyll derivatives and uses thereof |
| 12/22/2005 | WO2005120572A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins |
| 12/22/2005 | US20050283098 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
| 12/22/2005 | US20050282889 Intracorporeal medicaments for photodynamic treatment of disease |
| 12/22/2005 | US20050282873 Epothilone derivative for the treatment of hepatoma and other cancer diseases |
| 12/22/2005 | US20050281777 Photo-triggered release of active substances from dendrimer-photosensitizer complexes |
| 12/22/2005 | US20050281741 Using cyanine dyes; in situ target tumor cells |
| 12/22/2005 | CA2569675A1 Cationic bacteriochlorophyll derivatives and uses thereof |
| 12/22/2005 | CA2568744A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins |
| 12/22/2005 | CA2564197A1 Activatable particles, preparations and uses |
| 12/21/2005 | EP1605937A1 Treatment of proliferative diseases with epothilone derivatives and radiation |
| 12/21/2005 | EP1605847A2 Antibody-targeted photodynamic therapy |
| 12/21/2005 | EP1276501B1 Method for treatment of tumors using photodynamic therapy |
| 12/20/2005 | US6977168 Methods and compositions for treating nephrotic syndrome |